WESTFORD, Mass., June 2 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that President and Chief Executive Officer Michael Davin and Timothy Baker, the company’s Executive Vice President, Treasurer and Chief Financial Officer, will present at two upcoming investor conferences.
- On Tuesday, June 8 at 8:00 a.m. (ET), management will present at the Jefferies 2010 Global Life Sciences Conference in New York City.
- On Wednesday, June 9 at 10:00 a.m. (ET), the company will present at the 9th Annual Needham Healthcare Conference in New York City.
To access the live or archived webcasts of these events, visit the “Investor Relations” section of Cynosure’s website, www.cynosure.com.
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis and temporarily reduce the appearance of cellulite. Cynosure’s products include a broad range of laser and other light-based energy sources, including Alexandrite, pulsed dye, Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure was founded in 1991. For corporate or product information, contact Cynosure at 800-886-2966, or visit www.cynosure.com.
Contact: | |
Scott Solomon | |
Vice President | |
Sharon Merrill Associates, Inc. | |
617.542.5300 | |
SOURCE Cynosure, Inc.
